202 related articles for article (PubMed ID: 32580988)
1. Identification of cardiovascular and molecular prognostic factors for the medium-term and long-term outcomes of sepsis (ICROS): protocol for a prospective monocentric cohort study.
Coldewey SM; Neu C; Baumbach P; Scherag A; Goebel B; Ludewig K; Bloos F; Bauer M
BMJ Open; 2020 Jun; 10(6):e036527. PubMed ID: 32580988
[TBL] [Abstract][Full Text] [Related]
2. Identification of cardiovascular and molecular prognostic factors for the morbidity and mortality in COVID-19-sepsis (ICROVID): Protocol for a prospective multi-centre cohort study.
Neu C; Baumbach P; Scherag A; Kortgen A; Götze J; Coldewey SM
PLoS One; 2022; 17(6):e0269247. PubMed ID: 35658058
[TBL] [Abstract][Full Text] [Related]
3. Body composition, mitochondrial oxygen metabolism and metabolome of patients with obesity before and after bariatric surgery (COMMITMENT): protocol for a monocentric prospective cohort study.
Neu C; Skitek K; Kissler H; Baumbach P; Settmacher U; Esper Treml R; Coldewey SM
BMJ Open; 2022 Jun; 12(6):e062592. PubMed ID: 35925679
[TBL] [Abstract][Full Text] [Related]
4. Sepsis Care Pathway 2019.
Labib A
Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
[No Abstract] [Full Text] [Related]
5. Effects of evidence-based ICU care on long-term outcomes of patients with sepsis or septic shock (ILOSS): protocol for a multicentre prospective observational cohort study in Japan.
Liu K; Kotani T; Nakamura K; Chihiro T; Morita Y; Ishii K; Fujizuka K; Yasumura D; Taniguchi D; Hamagami T; Shimojo N; Nitta M; Hongo T; Akieda K; Atsuo M; Kaneko T; Sakuda Y; Andoh K; Nagatomi A; Tanaka Y; Irie Y; Kamijo H; Hanazawa M; Kasugai D; Ayaka M; Oike K; Lefor AK; Takahashi K; Katsukawa H; Ogura T
BMJ Open; 2022 Mar; 12(3):e054478. PubMed ID: 35351710
[TBL] [Abstract][Full Text] [Related]
6. Septic Cardiomyopathy.
Beesley SJ; Weber G; Sarge T; Nikravan S; Grissom CK; Lanspa MJ; Shahul S; Brown SM
Crit Care Med; 2018 Apr; 46(4):625-634. PubMed ID: 29227368
[TBL] [Abstract][Full Text] [Related]
7. The Septic Heart: Current Understanding of Molecular Mechanisms and Clinical Implications.
Martin L; Derwall M; Al Zoubi S; Zechendorf E; Reuter DA; Thiemermann C; Schuerholz T
Chest; 2019 Feb; 155(2):427-437. PubMed ID: 30171861
[TBL] [Abstract][Full Text] [Related]
8. A patient cohort on long-term sequelae of sepsis survivors: study protocol of the Mid-German Sepsis Cohort.
Scherag A; Hartog CS; Fleischmann C; Ouart D; Hoffmann F; König C; Kesselmeier M; Fiedler S; Philipp M; Braune A; Eichhorn C; Gampe C; Romeike H; Reinhart K;
BMJ Open; 2017 Aug; 7(8):e016827. PubMed ID: 28838900
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of septic cardiomyopathy: A narrative review.
Hiraiwa H; Kasugai D; Okumura T; Murohara T
Medicine (Baltimore); 2024 Apr; 103(17):e37940. PubMed ID: 38669408
[TBL] [Abstract][Full Text] [Related]
10. Elevated Plasma Histone H4 Levels Are an Important Risk Factor in the Development of Septic Cardiomyopathy.
Lu NF; Jiang L; Zhu B; Yang DG; Zheng RQ; Shao J; Yuan J; Xi XM
Balkan Med J; 2020 Feb; 37(2):72-78. PubMed ID: 31674172
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology, echocardiographic evaluation, biomarker findings, and prognostic implications of septic cardiomyopathy: a review of the literature.
Ehrman RR; Sullivan AN; Favot MJ; Sherwin RL; Reynolds CA; Abidov A; Levy PD
Crit Care; 2018 May; 22(1):112. PubMed ID: 29724231
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial Mechanisms in Septic Cardiomyopathy.
Cimolai MC; Alvarez S; Bode C; Bugger H
Int J Mol Sci; 2015 Aug; 16(8):17763-78. PubMed ID: 26247933
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of sepsis-induced cardiomyopathy.
Hollenberg SM; Singer M
Nat Rev Cardiol; 2021 Jun; 18(6):424-434. PubMed ID: 33473203
[TBL] [Abstract][Full Text] [Related]
14. Multicentre, longitudinal, observational cohort study to examine the relationship between neutrophil function and sepsis in adults and children with severe thermal injuries: a protocol for the Scientific Investigation of the Biological Pathways Following Thermal Injury-2 (SIFTI-2) study.
Hazeldine J; McGee KC; Al-Tarrah K; Hassouna T; Patel K; Imran R; Bishop JRB; Bamford A; Barnes D; Wilson Y; Harrison P; Lord JM; Moiemen NS
BMJ Open; 2021 Oct; 11(10):e052035. PubMed ID: 34686556
[TBL] [Abstract][Full Text] [Related]
15. [Elevated plasma histone is an independent risk factor for the development of septic cardiomyopathy].
Lu N; Zhu B; Yang D; Zheng R; Shao J; Xi X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Dec; 31(12):1457-1461. PubMed ID: 32029029
[TBL] [Abstract][Full Text] [Related]
16. The role of mitochondria in sepsis-induced cardiomyopathy.
Stanzani G; Duchen MR; Singer M
Biochim Biophys Acta Mol Basis Dis; 2019 Apr; 1865(4):759-773. PubMed ID: 30342158
[TBL] [Abstract][Full Text] [Related]
17. Protocol for a prospective observational study on the association of variables obtained by contrast-enhanced ultrasonography and sepsis-associated acute kidney injury.
Liu N; Zhang Z; Hong Y; Li B; Cai H; Zhao H; Dai J; Liu L; Qian X; Jin Q
BMJ Open; 2019 Jul; 9(7):e023981. PubMed ID: 31362958
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial Injury and Targeted Intervention in Septic Cardiomyopathy.
Tan Y; Chen S; Zhong J; Ren J; Dong M
Curr Pharm Des; 2019; 25(18):2060-2070. PubMed ID: 31284854
[TBL] [Abstract][Full Text] [Related]
19. Involvement of Mitochondrial Disorders in Septic Cardiomyopathy.
Durand A; Duburcq T; Dekeyser T; Neviere R; Howsam M; Favory R; Preau S
Oxid Med Cell Longev; 2017; 2017():4076348. PubMed ID: 29201271
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive use of physostigmine salicylate (Anticholium®) in perioperative sepsis and septic shock: study protocol for a randomized, double-blind, placebo-controlled, monocentric trial (Anticholium® per Se).
Zimmermann JB; Pinder N; Bruckner T; Lehmann M; Motsch J; Brenner T; Hoppe-Tichy T; Swoboda S; Weigand MA; Hofer S
Trials; 2017 Nov; 18(1):530. PubMed ID: 29126416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
